3 Companies with High Promoter Stake Sale in 2025 and How They Fared

Examining promoter stakes is crucial as it offers investors insight into a company's intent, level of confidence, and governance standards. Fundamentally, a high and steady promoter stake reflects a vested interest in the business's success.

However, interpreting a promoter stake sale requires careful consideration of its context.

For instance, in one of the companies highlighted here, the stake sale primarily was an exit. In another case, it was reclassification of promoters as normal shareholders.

Thus, understanding the broader circumstances is essential before forming conclusions. With that in mind, here are three companies that have recently witnessed a promoter stake sales.

#1 AWL Agri Business

First on our list is the stock of AWL Agri Business.

The company is a major Indian food & agribusiness company, known primarily for producing and selling essential kitchen staples like edible oils, rice, wheat flour (atta), pulses, and sugar under well-known brands (most notably Fortune) as well as other FMCG products.

The Adani Group fully exited its promoter stake in AWL Agri Business (formerly Adani Wilmar Limited) in November 2025.

The total promoter holdings of AWL Agri Business has now dropped from 63.94% as at the end of September 2025 to 56.94% as at the end of December 2025.

Since November, when the stake sale happened, the stock has fallen from levels of Rs 274 to Rs 214 (as on 16 January 2025). However, this could be due to other factors, including quarterly numbers and not necessarily a promoter exit.

Promoter Holding

Source: Equitymaster

On the financial front, AWL Agri Business reported total revenue of Rs 176,046 million (m) in Q2 FY26, against Rs 144,499 m YoY. The net profit dropped to Rs 2,276 m vs Rs 2,819 YoY.

AWL Agri Business recently released its Q3 business update.

During the quarter ended on 31 December 2025, the company recorded a low single digit growth in volumes. Growth was primarily led by an uptick in both the edible oil and food & FMCG segment.

However, the overall volumes were dragged by de-growth in castor and de-oiled cakes classified under the industry essentials segment. Festive demand was relatively subdued during the quarter as trade continued to operate with lean inventory levels.

#2 Aptus Value Housing Finance

Aptus Value Housing is an Indian housing finance company focused on providing affordable home loans and related lending products, especially to low and middle-income self-employed individuals in rural and semi-urban areas.

The promoter holdings fell significantly by the end of September 2025 quarter to 23.87% from 40.37% in the previous quarter ending June 2025.

WestBridge formally applied for reclassification from "Promoter/Promoter Group" to "Public" category under SEBI rules. This could be one of the reasons for drop in promoter holdings.

In the last six months, the stock has dropped significantly from levels of Rs 340 on 16 July 2025, to current levels of Rs 270 on 16 January 2026.

Promoter Holding

Source: Equitymaster

On the financial front, net interest income grew to Rs 3,790 m in Q2 FY26, against Rs 2,934 m YoY. The net profit moved in tandem higher to Rs 2,265 m vs Rs 1,820 YoY.

On asset quality, the GNPA moved higher by 6 basis points to 1.55%. The company has strengthened its collections at the state level, whereby collections are being pursued to reduce the GNPA.

Moving ahead, Aptus Housing plans to reach Rs 250 bn in assets under management in the medium term. The aim is to build see a 25%+ growth driven by expanding footprint and consistent execution.

The other key initiative that the company is undertaking is to offer diverse products and broaden the customer base. The balanced growth across housing and small business loans continue to support portfolio stability and earning consistency.

The company plans to expand rapidly beyond the southern markets and is seeing encouraging response across Maharashtra and Odisha.

#3 Cohance Lifesciences

Next on our list is the stock of Cohance Lifesciences.

Cohance Lifesciences is an Indian pharmaceutical and life sciences company focused on contract development and manufacturing (CDMO) and active pharmaceutical ingredients (API) services for global drug makers, biotech firms, and specialty chemical companies.

Promoter Holding

Source: Equitymaster

The promoter holdings significantly dropped by the end of September 2025 quarter to 57.49% from 66.41% in the previous quarter ending June 2025.

Promoter Jusmiral Holdings offloaded 8.9% stake in Cohance Lifesciences, via open market transactions on 18 September.

Interestingly, mutual funds increased their stake by 7.59%. As of September 2025, mutual funds held 16.49% stake in the company.

On the financial front, Cohance Lifesciences reported a drop in total revenue to Rs 5,556 m in Q2 FY26, against Rs 6,038 m YoY. The net profit halved to Rs 664 m vs Rs 1,382 YoY.

During the quarter, the company's late phase molecules in the respiratory inflammatory segment received US regulatory approval. This opens up a multi-year commercial revenue stream as the product runs post-launch.

The company is currently executing 9 Phase III molecules of which 4 are expected to transition into commercial supply over the next 12-18 months, and two have moved into launch-stage delivery.

The company's API site at Jaggaiahpet cleared the US FDA audit with zero observations. This plant contributes a larger share of the total revenue.

Investors should evaluate the company's fundamentals, corporate governance, and valuations of the stock as key factors when conducting due diligence before making investment decisions.

Disclaimer: This article is for information purposes only. It is not a stock recommendation and should not be treated as such. Learn more about our recommendation services here...